Tag archive for ‘Yossi Ben-Yossef’
Jewish Business News On Monday, October 6th, 2014

Kadimastem Approached the FDA Regarding Its ALS Treatment

– The company recently reported positive results in its first pre-clinical trial for the treatment of ALS. – Israeli biotechnology company Kadimastem announces today that it approached the FDA regarding More...

Jewish Business News On Sunday, August 3rd, 2014

Kadimastem to collaborate with Merck Serono

–   Israeli biotechnology company Kadimastem (TASE: KDST) has signed a collaboration agreement with Merck to carry out drug screening in the neurodegenerative diseases space for multiple sclerosis More...

Merck Serono and Kadimastem Sign MOU on Drug Screening and Discovery for Neurodegenerative Diseases

–  Yossi Ben-Yossef, CEO and Founder of Kadimastem German global pharmaceutical company Merck Serono, and Israeli Kadimastem (TASE:KDST) , a developer of human pluripotent stem cell-based More...

Wordpress site Developed by Fixing WordPress Problems